February 2009 Volume 43 Number 4, pp 265 - 348
---------------------------------------------------------------------
Cool new website, Hot science jobs!
Naturejobs is pleased to announce naturejobs.com has a new and
improved look and functionality making your online experience even
better!
Check out our redesign and find thousands of scientific vacancies,
careers information, podcasts, advertising options and more!
http://links.ealert.nature.com/ctt?kn=74&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=66&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
to start your subscription today.
----------------------
REVIEW
----------------------
Palliative care in BMT
H M Chung, L J Lyckholm and T J Smith
Abstract: http://links.ealert.nature.com/ctt?kn=38&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=78&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
----------------------
SPECIAL REPORT
----------------------
The EBMT activity survey 2007 with focus on allogeneic HSCT for AML
and novel cellular therapies
A Gratwohl, H Baldomero, A Schwendener, V Rocha, J Apperley,
K Frauendorfer and D Niederwieser
Abstract: http://links.ealert.nature.com/ctt?kn=4&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=6&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Immunogenic disparities of 11 minor histocompatibility antigens (mHAs)
in HLA-matched unrelated allogeneic hematopoietic SCT
M Markiewicz, U Siekiera, A Karolczyk, J Szymszal, G Helbig, J Wojnar,
M Dzierzak-Mietla and S Kyrcz-Krzemien
Abstract: http://links.ealert.nature.com/ctt?kn=12&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=14&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Actual or ideal body weight to calculate CD34+ cell dose in patients
undergoing autologous hematopoietic SCT for myeloma?
V Singh, J Krishnamurthy, S Duffey, R Meagher, M Villa, J Monreal,
A Evens, O Frankfurt, J Altman, L Gordon, M Tallman, S Williams, J Winter,
S Singhal and J Mehta
Abstract: http://links.ealert.nature.com/ctt?kn=39&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=26&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Early outcomes after allogeneic hematopoietic SCT in pediatric patients with
hematologic malignancies following single fraction TBI
T E Druley, R Hayashi, D B Mansur, Q (Jean) Zhang, Y Barnes, K Trinkaus,
S Witty, T Thomas, E E Klein, J F DiPersio, D Adkins and S Shenoy
Abstract: http://links.ealert.nature.com/ctt?kn=61&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=3&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Poor outcome in post transplant lymphoproliferative disorder with pulmonary
involvement after allogeneic hematopoietic SCT: 13 years' experience in a
single institute
H-A Hou, M Yao, J-L Tang, Y-K Chen, B-S Ko, S-Y Huang, H-F Tien, H-H Chang,
M-Y Lu, T-T Lin, K-H Lin, C-H Hsiao, C-W Lin and Y-C Chen
Abstract: http://links.ealert.nature.com/ctt?kn=22&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=70&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Prognostic impact of diffuse large B-cell lymphoma subgroups in patients
undergoing autologous SCT
A E Hallack Neto, F L Dulley, S A Coelho Siqueira, L F Pracchia, M Belesso,
R Saboya, D Sturaro, J U Amigo-Filho, A Mendrone Junior, D A F Chamone and J Pereira
Abstract: http://links.ealert.nature.com/ctt?kn=59&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=48&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Response and toxicity of donor lymphocyte infusions following T-cell depleted
non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors
D A Rizzieri, P Dev, G D Long, C Gasparetto, K M Sullivan, Ml Horwitz, J Chute
and N J Chao
Abstract: http://links.ealert.nature.com/ctt?kn=60&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=73&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Molecular epidemiological investigation of an outbreak of Pseudomonas aeruginosa
infection in an SCT unit
R Fanci, B Bartolozzi, S Sergi, E Casalone, P Pecile, D Cecconi, R Mannino,
F Donnarumma, A G Leon, S Guidi, P Nicoletti, G Mastromei and A Bosi
Abstract: http://links.ealert.nature.com/ctt?kn=50&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=32&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Alefacept treatment for refractory chronic extensive GVHD
M Y Shapira, A Abdul-Hai, I B Resnick, M Bitan, P Tsirigotis, M Aker, B Gesundheit,
S Slavin and R Or
Abstract: http://links.ealert.nature.com/ctt?kn=54&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=71&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
Acute cellular rejection in a renal allograft immediately following leukocyte
engraftment after auto-SCT
N Leung, J M Gloor, P G Dean, M Q Lacy, L F Porrata and M D Griffin
http://links.ealert.nature.com/ctt?kn=80&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
Sezary syndrome in relapse after reduced intensity allogeneic transplant
successfully treated with donor lymphocyte infusion
L Cudillo, R Cerretti, G Baliva, G De Angelis, M Postorino, A Picardi,
M Mirabile, A Lanti, M Cantonetti and W Arcese
http://links.ealert.nature.com/ctt?kn=64&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
---------------------------------------------------------------------
Announcing an open access option in British Journal of Cancer.
An open access option is now available to all authors of original
research papers that are accepted for publication in BJC.
BJC OPEN articles will be freely accessible to all readers
immediately on publication.
Learn more about BJC OPEN by visiting BJC online at
http://links.ealert.nature.com/ctt?kn=33&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0 .
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=25&m=31721444&r=MTc1NjE0NTQ4OQS2&b=2&j=NDYxNDI3ODcS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
